JPH0125722B2 - - Google Patents

Info

Publication number
JPH0125722B2
JPH0125722B2 JP56025058A JP2505881A JPH0125722B2 JP H0125722 B2 JPH0125722 B2 JP H0125722B2 JP 56025058 A JP56025058 A JP 56025058A JP 2505881 A JP2505881 A JP 2505881A JP H0125722 B2 JPH0125722 B2 JP H0125722B2
Authority
JP
Japan
Prior art keywords
group
benzimidazole
anthelmintic
antibiotics
salicylamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56025058A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57139012A (en
Inventor
Kunitoshi Kitano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12155318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH0125722(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to JP56025058A priority Critical patent/JPS57139012A/ja
Priority to DE8282300829T priority patent/DE3260921D1/de
Priority to DE2002199008 priority patent/DE10299008I2/de
Priority to EP82300829A priority patent/EP0059074B1/en
Priority to GB8204765A priority patent/GB2093695B/en
Priority to IE369/82A priority patent/IE52364B1/en
Priority to ZA821135A priority patent/ZA821135B/xx
Priority to US06/350,641 priority patent/US4468390A/en
Priority to NZ199817A priority patent/NZ199817A/en
Priority to AU80711/82A priority patent/AU552403B2/en
Publication of JPS57139012A publication Critical patent/JPS57139012A/ja
Publication of JPH0125722B2 publication Critical patent/JPH0125722B2/ja
Priority to NL300082C priority patent/NL300082I1/nl
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56025058A 1981-02-23 1981-02-23 Anthelmintic composition Granted JPS57139012A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP56025058A JPS57139012A (en) 1981-02-23 1981-02-23 Anthelmintic composition
DE8282300829T DE3260921D1 (en) 1981-02-23 1982-02-18 Anthelmintic composition and the use thereof
DE2002199008 DE10299008I2 (de) 1981-02-23 1982-02-18 Anthelmintische Zusammensetzung un ihre Verwendung.
EP82300829A EP0059074B1 (en) 1981-02-23 1982-02-18 Anthelmintic composition and the use thereof
GB8204765A GB2093695B (en) 1981-02-23 1982-02-18 Anthelmintic composition containing macrolide antibiotics
US06/350,641 US4468390A (en) 1981-02-23 1982-02-22 Anthelmintic composition and the use thereof
ZA821135A ZA821135B (en) 1981-02-23 1982-02-22 Anthelmintic composition and the use thereof
IE369/82A IE52364B1 (en) 1981-02-23 1982-02-22 Anthelmintic composition and the use thereof
NZ199817A NZ199817A (en) 1981-02-23 1982-02-23 Anthelmintic composition consisting of two components
AU80711/82A AU552403B2 (en) 1981-02-23 1982-02-23 Anthelmintic composition and use
NL300082C NL300082I1 (nl) 1981-02-23 2002-02-13 Anthelmintische samenstelling en het gebruik daarvan.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56025058A JPS57139012A (en) 1981-02-23 1981-02-23 Anthelmintic composition

Publications (2)

Publication Number Publication Date
JPS57139012A JPS57139012A (en) 1982-08-27
JPH0125722B2 true JPH0125722B2 (https=) 1989-05-19

Family

ID=12155318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56025058A Granted JPS57139012A (en) 1981-02-23 1981-02-23 Anthelmintic composition

Country Status (10)

Country Link
US (1) US4468390A (https=)
EP (1) EP0059074B1 (https=)
JP (1) JPS57139012A (https=)
AU (1) AU552403B2 (https=)
DE (2) DE10299008I2 (https=)
GB (1) GB2093695B (https=)
IE (1) IE52364B1 (https=)
NL (1) NL300082I1 (https=)
NZ (1) NZ199817A (https=)
ZA (1) ZA821135B (https=)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753377B1 (fr) * 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
US6426333B1 (en) * 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
MA19678A1 (fr) * 1982-01-13 1983-10-01 Ciba Geigy Ag Agents anti-helmintiques.
DE3410348A1 (de) * 1984-03-21 1985-10-03 Helmut Dr. Bozen Schwienbacher Verfahren zur bekaempfung von fischmykosen und mittel zur durchfuehrung des verfahrens
ES2054962T3 (es) * 1986-01-25 1994-08-16 Hoechst Ag Agentes plaguicidas.
GB9024924D0 (en) * 1990-11-16 1991-01-02 Beecham Group Plc Novel compositions
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
AU2003236405B2 (en) * 1999-04-14 2007-10-25 Merial Ltd Anthelmintic Composition
AU691990B2 (en) * 1994-11-28 1998-05-28 Virbac S.A. Equine anthelmintic formulations
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
FR2739778B1 (fr) * 1995-10-13 1997-12-12 Virbac Lab Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal
CA2259469A1 (en) 1996-06-05 1997-12-11 Ashmont Holdings Limited Injectable compositions
DE19654079A1 (de) 1996-12-23 1998-06-25 Bayer Ag Endo-ekto-parasitizide Mittel
US6733767B2 (en) * 1998-03-19 2004-05-11 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US20040077703A1 (en) * 2002-10-02 2004-04-22 Soll Mark D. Nodulisporic acid derivative spot-on formulations for combating parasites
BRPI0409185B1 (pt) * 2003-04-04 2018-05-15 Merial, Inc Formulações veterinárias anti-helmínticas tópicas
ATE534900T1 (de) * 2003-07-09 2011-12-15 Life Technologies Corp Verfahren zum testen einer protein-protein- wechselwirkung
US7396819B2 (en) 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
US7671034B2 (en) 2003-12-19 2010-03-02 Merial Limited Stabilized formulation of ivermectin feed premix with an extended shelf life
WO2005094210A2 (en) 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
US20050226908A1 (en) * 2004-04-07 2005-10-13 Akzo Nobel N.V. Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use
GB0508993D0 (en) * 2005-05-03 2005-06-08 Syngenta Participations Ag Pesticidal compositions
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
CA2656617C (en) 2006-07-05 2014-10-14 Aventis Agriculture 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
US7919522B2 (en) * 2007-05-03 2011-04-05 Merial Limited Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds
ES2597083T3 (es) 2007-05-15 2017-01-13 Merial, Inc. Compuestos de ariloazol-2-il cianoetilamino, procedimiento de fabricación y procedimiento de utilización de los mismos
CA2706448C (en) 2007-11-26 2016-08-16 Merial Limited Solvent systems for pour-on formulations for combating parasites
WO2010042395A1 (en) 2008-10-08 2010-04-15 Wyeth Llc Benzimidazole anthelmintic compositions
MY153715A (en) 2008-11-14 2015-03-13 Merial Ltd Enantiomerically enriched aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
ES2781828T3 (es) 2008-11-19 2020-09-08 Boehringer Ingelheim Animal Health Usa Inc Composiciones que comprenden un aril pirazol y/o una formamidina, procedimientos y usos de las mismas
BRPI1009199A2 (pt) 2009-03-17 2016-03-08 Concert Pharmaceuticals Inc compostos de pirazinoisoquinolina
ES2546100T3 (es) 2009-12-04 2015-09-18 Merial, Inc. Compuestos pesticidas bis-organosulfurados
EP3078664B1 (en) 2009-12-17 2019-02-20 Merial Inc. Antiparasitic dihydroazole compositions
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
NZ610547A (en) 2010-11-16 2015-07-31 Merial Ltd Novel monensin derivatives for the treatment and prevention of protozoal infections
WO2013003168A1 (en) 2011-06-27 2013-01-03 Merial Limited Novel insect-repellent coumarin derivatives, syntheses, and methods of use
ES2618813T3 (es) 2011-06-27 2017-06-22 Merial, Inc. Compuestos y composiciones de éter amido-piridílico y uso contra los parásitos
PL3172964T3 (pl) 2011-09-12 2021-03-08 Boehringer Ingelheim Animal Health USA Inc. Kompozycje przeciwpasożytniczne zawierające izoksazolinową substancję czynną, sposób i ich zastosowania
US20130079394A1 (en) 2011-09-23 2013-03-28 Cnrs (Centre National Recherche Scientifique) Indirect modeling of new repellent molecules active against insects, acarids, and other arthropods
CN104023720B (zh) 2011-11-17 2016-10-26 梅里亚有限公司 包含芳基吡唑和取代咪唑的组合物，其方法和用途
LT2811998T (lt) 2012-02-06 2019-02-25 Merial, Inc. Paraziticidinės peroralinės veterinarinės kompozicijos, apimančios sistemiškai veikiančius aktyviuosius agentus, būdai ir jų panaudojimas
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
NZ701185A (en) 2012-04-20 2015-08-28 Merial Ltd Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
PL2922845T3 (pl) 2012-11-20 2018-11-30 Merial, Inc. Związki przeciwrobacze oraz ich kompozycje i sposób stosowania
SMT201800309T1 (it) 2013-01-31 2018-07-17 Merial Inc Metodo per trattare e curare leishmaniosi utilizzando fexinidazolo
DK3063144T3 (da) 2013-11-01 2021-10-25 Boehringer Ingelheim Animal Health Usa Inc Antiparasitære og pesticid-isoxazolinforbindelser
BR112016023898A8 (pt) 2014-04-17 2021-03-30 Basf Se uso de compostos malononitrila para proteger animais de parasitas
CA2949511A1 (en) 2014-05-19 2015-11-26 Merial, Inc. Anthelmintic compounds
CN106536481B (zh) 2014-06-19 2019-11-22 勃林格殷格翰动物保健美国公司 包含吲哚衍生物的杀寄生物的组合物、其用法和用途
WO2016069983A1 (en) 2014-10-31 2016-05-06 Merial, Inc. Parasiticidal composition comprising fipronil
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
EA036272B1 (ru) 2015-04-08 2020-10-21 БЁРИНГЕР ИНГЕЛЬХАЙМ ЭНИМАЛ ХЕЛТ ЮЭсЭй ИНК. Инъецируемые препараты замедленного высвобождения, содержащие изоксазолиновое действующее вещество, способы и применение
CN107835818B (zh) 2015-05-20 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
EP3303385A2 (en) 2015-05-27 2018-04-11 Merial, Inc. Compositions containing antimicrobial igy antibodies, for treatment and prevention of disorders and diseases caused by oral health compromising (ohc) microorganisms
UY40429A (es) 2016-02-24 2023-10-13 Boehringer Ingelheim Animal Health Usa Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
AU2017344097A1 (en) 2016-10-14 2019-05-02 Boehringer Ingelheim Animal Health USA Inc. Pesticidal and parasiticidal vinyl isoxazoline compounds
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
US11147273B2 (en) 2017-06-26 2021-10-19 Boehringer Ingelheim Animal Health USA Inc. Dual active parasiticidal granule compositions, methods and uses thereof
MX2020001724A (es) 2017-08-14 2020-07-29 Boehringer Ingelheim Animal Health Usa Inc Compuestos de pirazol-isoxazolina plaguicidas y parasiticidas.
US11583545B2 (en) 2018-02-08 2023-02-21 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
US12269822B2 (en) 2018-07-09 2025-04-08 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic heterocyclic compounds
WO2020112374A1 (en) 2018-11-20 2020-06-04 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
WO2020150032A1 (en) 2019-01-16 2020-07-23 Boehringer Ingelheim Animal Health USA Inc. Topical compositions comprising a neonicotinoid and a macrocyclic lactone, methods and uses thereof
UY38599A (es) 2019-03-01 2020-08-31 Boehringer Ingelheim Animal Health Usa Inc Composiciones inyectables de clorsulón, sus métodos y usos
MX2021011302A (es) 2019-03-19 2022-01-19 Boehringer Ingelheim Animal Health Usa Inc Compuestos de aza-benzotiofeno y aza-benzofurano como antihelminticos.
EP4003292A1 (en) 2019-07-22 2022-06-01 Intervet International B.V. Soft chewable veterinary dosage form
KR20230028268A (ko) 2020-05-29 2023-02-28 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 헤테로시클릭 화합물
CN116897044A (zh) 2020-12-21 2023-10-17 勃林格殷格翰动物保健有限公司 包含异噁唑啉化合物的杀寄生虫环
WO2025257633A1 (en) 2024-06-12 2025-12-18 Boehringer Ingelheim Vetmedica Gmbh Long-acting castor oil-containing injectable formulations and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914624A (https=) * 1972-06-08 1974-02-08
PH15982A (en) * 1977-10-03 1983-05-18 Merck & Co Inc Selective hydrogenation producta of c-076 compounds and derivatives thereof
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4203976A (en) * 1978-08-02 1980-05-20 Merck & Co., Inc. Sugar derivatives of C-076 compounds
US4289760A (en) * 1980-05-02 1981-09-15 Merck & Co., Inc. 23-Keto derivatives of C-076 compounds

Also Published As

Publication number Publication date
EP0059074A1 (en) 1982-09-01
IE52364B1 (en) 1987-09-30
ZA821135B (en) 1983-02-23
JPS57139012A (en) 1982-08-27
DE10299008I1 (de) 2002-07-04
NL300082I1 (nl) 2002-04-02
US4468390A (en) 1984-08-28
IE820369L (en) 1982-08-23
EP0059074B1 (en) 1984-10-10
GB2093695A (en) 1982-09-08
AU8071182A (en) 1982-09-02
NZ199817A (en) 1984-12-14
DE3260921D1 (en) 1984-11-15
GB2093695B (en) 1984-03-28
AU552403B2 (en) 1986-05-29
DE10299008I2 (de) 2004-10-21

Similar Documents

Publication Publication Date Title
JPH0125722B2 (https=)
Finlay et al. Viomycin, a new antibiotic active against mycobacteria
CN108699052B (zh) 驱虫缩酚酸肽化合物
Rood et al. Isolation and characterization of multiply antibiotic-resistant Clostridium perfringens strains from porcine feces
Girard et al. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution
CN107835818B (zh) 驱虫缩酚酸肽化合物
DE69633734T2 (de) Antibakterielle nitroimidazolverbindungen und verfahren zu deren verwendung
DE68920673T2 (de) 13-Substituierte Milbemycinderivate, ihre Herstellung und Verwendung.
AU2009308180B2 (en) Methods for treating gastrointestinal diseases
RS54904B1 (sr) Antibakterijske farmaceutske kompozicije
Hirano et al. Structure–activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents
Sanfilippo et al. Biological activity of a new class of rifamycins Spiro-piperidyl-rifamycins
JPS63119486A (ja) Ｌｌ−ｆ２８２４９化合物の２３−オキソ（ケト）および２３−イミノ誘導体
AU658268B2 (en) Antiparasitic avermectin and milbemycin derivatives
WO2005007143A2 (en) Use of makrolides and ketolides for the treatment of tuberculosis
EP0222186B1 (en) Erythromycin derivatives /a
DE60025370T2 (de) 9a-azalide mit antibakterieller wirkung
EP1134216B1 (en) Anti-drug resistant strain agents and antichlamydia agents
DE60133273T2 (de) Inhibitoren von peptid deformylase
US4794105A (en) Method for treatment of swine dysentery
DE60112280T2 (de) Inhibitoren von peptid-deformylase
Muri et al. Anti-Helicobacter pylori agents. An update
Woodruff et al. The antibiotics explosion
CN104177373A (zh) 抗结核化合物imb-cc223
CN110981888A (zh) N-芳基二硫吡咯酮脲类和氨基酯类衍生物及其制备和应用